Recommeneded Maintenance Dosage in Ulcerative Colitis and Crohn's Direase
* Week 10 and thereafter: Inject 120 mg subcutaneously once every two weeks. * To swift patients who are responding to maintenance therapy with an infliximab product administered intravenously, administer the first subcutaneous dose of ZYMFENTRA in place of the next scheduled intravenous infusion and every two weeks thereafter. * See the full prescribing information on how to administer subcutaneously.
Get Your Patient on Zymfentra
See your patient's specific prior authorization requirements including coverage restrictions and step therapies